food and drug administration news

FDA Approves 1st New Schizophrenia Drug in Decades

FDA Approves the First New Schizophrenia Drug in Decades

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely different way from existing medications for schizophrenia, which is building excitement and enthusiasm among doctors and patients alike.

Barron's on MSN · 1h

Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking.

Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This drug takes the first new approach to schizophrenia treatment in decades,” the Food and Drug Administration said.

92.7 WMAY · 51m

FDA approves first new drug for schizophrenia in more than 30 years

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers

FDA issues recall notices for two brands of pet food

YAHOO!News · 19h

FDA issues recall notices for two brands of pet food over salmonella and listeria contamination

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them

USA TODAY on MSN · 1d

ANSWERS Pet Food recalled over salmonella, listeria concerns: What pet owners need to know

ANSWERS Pet Food is voluntarily recalling several of its products due to potential salmonella and listeria exposure, according to the FDA.

FOX News on MSN · 2d

Pet food recalled over possible salmonella, listeria contamination

Dog food sold online and in stores is being recalled after tests conducted by federal health officials revealed the presence of both listeria and salmonella.

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 20h

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Business Insider · 19h

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.

MarketWatch · 21h

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

The Washington Post16h

FDA approves a novel drug for schizophrenia, a potential ‘game changer’

The U.S. Food and Drug Administration late Thursday approved a new kind of drug to treat schizophrenia, a ...

46mon MSN

These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava, Wynn, HP Inc., Acadia Healthcare, and More

Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...

BioPharma Dive1h

FDA, after delay, clears Regeneron and Sanofi drug for COPD

Dupixent is the first biologic medicine approved in the U.S. for the common lung condition, though competitors from GSK, AstraZeneca and Roche could follow.

We need a Food and Drug Administration for AI

We wouldn’t allow a new drug to be sold without thorough testing for safety and efficacy, so why should AI be any different?

FDA Approves New Schizophrenia Drug in 70-Year First

The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults ...

McKnight's Long-Term Care News17h

Journalists question safety and effectiveness of new Alzheimer’s drug

A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...

19h

The overdose reversal drug Narcan is being distributed in old newspaper boxes

Naloxone, a nasal spray most commonly known as Narcan, is used as an emergency treatment to reverse drug overdoses.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results